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Abstract: The genes encoding Anthrax Toxin Receptors (ANTXRs) were originally 
identified based on expression in endothelial cells suggesting a role in angiogenesis. The 
focus of this review is to discuss what has been learned about the physiological roles of 
these receptors through evaluation of the Antxr knockout mouse phenotypes. Mice mutant 
in Antxr genes have defects in extracellular matrix homeostasis. We discuss how 
knowledge of physiological ANTXR function relates to what is already known about 
anthrax intoxication. 




Anthrax Toxin Receptor 1 (ANTXR1) and Anthrax Toxin Receptor 2 (ANTXR2) are the human 
proteins that serve as receptors for anthrax toxin [1,2], a discovery made ten years ago. Since that time, 
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there has been an intense research effort to tell the story of how toxin interaction with these receptors 
leads to anthrax intoxication (reviewed in [3–5]). Although the ANTXR proteins evolved for a 
physiological function, they were eventually hijacked to facilitate entry of a lethal agent produced by 
the pathogen, Bacillus anthracis. In this review, we summarize recent reports on the normal function 
of anthrax receptors. We discuss studies that uncover the physiological function of ANTXR1 and 
ANTXR2, with a focus on analysis of the Antxr1 and Antxr2 knockout mouse phenotypes. 
2. Discovery of the ANTXR Genes 
At the turn of the 21st century, targeting angiogenesis, the process by which new blood vessels 
sprout from pre-existing blood vessels, was recognized as an attractive therapeutic strategy for treating 
numerous pathological processes such as tumor growth, atherosclerosis and diabetic retinopathy. To 
that end, researchers performing discovery-based screens in either normal or disease associated 
endothelium identified novel proteins with putative roles in angiogenesis. One such screen led to the 
discovery of tumor endothelium marker 8 (TEM8), a gene that was found to be overexpressed in 
colorectal tumor endothelium compared to normal endothelium [6]. Similarly, capillary morphogenesis 
gene 2 (CMG2) was identified based on dramatically up-regulated expression in cultured human 
venous endothelial cells induced to undergo capillary morphogenesis in vitro [7]. Alternate splicing of 
the TEM8 and CMG2 genes result in multiple protein variants [1,2,6,7]. These splice variants have the 
potential to produce either membrane spanning (Figure 1) or secreted variants of TEM8 and CMG2, 
although new variants continue to be uncovered [8]. A detailed description of these variants is 
discussed in the literature (reviewed in [9]). 
Shortly after the discovery of the TEM8 and CMG2 genes, separate searches for the host receptor(s) 
for anthrax toxin led to the discovery that the proteins encoded by TEM8 and CMG2 functioned at the 
cell surface as anthrax toxin receptors [1,2]. Hence the official NCBI gene designations for the TEM8 
and CMG2 genes are ANTXR1 and ANTXR2, respectively. We will use the official NCBI nomenclature 
when referring to the genes and to the proteins derived from these genes; a designation that we 
advocate for use to help maintain consistency in the field. 




Figure 1. Proposed model for ANTXR regulation of MT1-MMP activity. MT1-MMP 
resides at the cell surface in its active form. MT1-MMP cleaves a variety of substrates 
including multiple ECM components. MT1-MMP also plays a role in MMP activation 
cascades, primarily in activation of pro MMP2. (A) The current accepted model for the 
generation of active MMP2 is that a ternary complex consisting of MT1-MMP/TIMP-2/pro 
MMP2 is cleaved by an adjacent active molecule of MT1-MMP to produce an intermediate 
form of MMP2. Fully active MMP2 is generated through trans activation by another active 
MMP2 protein; (B) ANTXRs bind putative ECM ligands including collagens and laminin. 
When ANTXRs and MT1-MMP are co-expressed, there is increased activation of MMP2, 
observed as decreased levels of pro MMP2. We propose that ANTXRs may interact with 
ECM components and facilitate multimerization and activation of ANTXR/MT1-MMP 
complex. ANTXRs may regulate MMP activity by (1) increasing MT1-MMP 
multimerization which, in turn increases pro MMP2 processing and by (2) mediating 
substrate specificity for MMPs. Pro: pro domain, vWF: von Willebrand factor, T: 
transmembrane domain, ID: intracellular domain, CAT: catalytic domain, H: hinge 
domain, HEM: hemopexin domain, S: stalk domain. 
 
3. Studies Reveal a Role for ANTXRs as Regulators of Angiogenesis and Cell-Matrix Interactions 
The original hypotheses regarding physiological Anthrax Toxin Receptor function in angiogenesis 
were based on expression in the endothelium. Consequently, many groups explored ANTXR function 




in endothelial cells. ANTXR1 has been demonstrated to be important for endothelial cell migration and 
capillary-like network formation [10,11]. Similarly, ANTXR2 is required for angiogenic processes 
such as endothelial proliferation and capillary-like network formation in vitro [12]. Given that the 
ANTXRs share structural similarities with α-integrin subunits, several groups also investigated 
whether extracellular matrix (ECM) proteins might serve as endogenous ligands for the ANTXRs. The 
extracellular domain of ANTXR1 has been shown to interact with collagen type I, the α3 subunit of 
collagen type VI, and gelatin [10,13]. Similarly, the extracellular domain of ANTXR2 has been shown 
to interact with collagen type IV and laminin [7]. Fibroblasts expressing mutant ANTXR2 protein 
exhibited deficient interactions with laminin, but not with collagen types I or IV [14]. Each of these 
studies took an approach that targeted specific ECM components when characterizing ANTXR/ECM 
interactions. Future studies evaluating interactions between each ANTXR and a wide array of ECM 
proteins will help determine whether ANTXRs exhibit specificity or promiscuity in their ligand 
binding abilities. It is also of interest that like integrins, ANTXR1 was shown to mediate cell spreading 
through association with the actin cytoskeleton [15]. Further evidence that the ANTXRs possess 
integrin-like qualities comes from a recent report where ANTXR1 was demonstrated to colocalize with 
alpha-smooth muscle actin at the cell surface. Co-immunoprecipitation experiments confirmed that the 
two proteins interact [16]. Exploration of antibodies that detect either masked or unmasked forms of 
ANTXR1 led to the hypothesis that ANTXR1, like integrins, exists in either an open or closed 
confirmation that is dependent upon receptor binding to the actin cytoskeleton [16]. Support for this 
hypothesis comes from recent studies demonstrating that anthrax toxin may take advantage of 
ANTXR/cytoskeletal interactions to process PA and that the cytoskeleton, in turn, is a target of anthrax 
toxin (reviewed in [17]). Collectively, these reports provide evidence that ANTXRs function as 
important regulators of cell-matrix interactions underlying various biological processes. 
4. Antxr1 Knockout Mice Demonstrate a Role for Antxr1 in Tumor Endothelium and Beyond  
To elucidate ANTXR1 function, two independent groups generated Antxr1 knockout (KO)  
mice [18,19]. The Leppla group targeted exon 13 of the Antxr1 gene for deletion [18]. Exon 13 
encodes the transmembrane domain of the Antxr1 protein. This targeting strategy would result in a 
protein consisting of the extracellular domain of Antxr1, which can be detected in the mutant  
mice [18]. These mice have likely lost normal Antxr1 function, but may retain some activities 
associated with the extracellular domain of Antxr1. Thus, we will refer to these mice as Antxr1 mutant 
mice. The Antxr1 mutant mice were used to evaluate receptor-mediated anthrax pathogenesis, and 
provided definitive evidence that gene deficiency affected anthrax intoxication. Beyond a role in 
intoxication, they noted that Antxr1 mutant mice developed progressively misaligned incisors, and that 
female Antxr1 mutant mice could get pregnant but failed to support normal embryonic  
development [18]. Thus, they established that diverse phenotypes arise from Antxr1 deficiency.  
The St. Croix group targeted exon 1 of the Antxr1 gene for deletion, which encodes part of the 
Antxr1 promoter, the start codon and the signal peptide [19]. This targeting strategy would not be 
predicted to make Antxr1 protein and we will refer to these mice as Antxr1 KO mice. Heterozygous 
intercrosses yielded Antxr1 KO mice at the expected Mendelian ratios demonstrating that Antxr1 is 
dispensable for embryonic development. The researchers confirmed that Antxr1 transcripts and protein 




were not being expressed in the Antxr1 KO mice by implanting tumors in wild-type (WT) and KO 
mice and then isolating tumor endothelial cells for RT-PCR and Western blot analysis. This approach 
was selected since Antxr1 is highly expressed in tumor endothelial cells. Although endothelial Antxr1 
expression had been demonstrated to be important for angiogenic processes in vitro, evaluation of 
physiological and pathological angiogenic processes did not reveal overt angiogenic defects in Antxr1 
KO mice. With regards to physiological angiogenesis, there were no significant differences observed 
in the vasculature from Antxr1 WT and KO mouse excisional wounds analyzed 7 days post wounding, 
nor were there alterations in the developing retinal vasculature when analyzed on postnatal days 3.5 
through 11.5. Pathological angiogenesis in the Antxr1 KO mice also appeared to be unaltered, when 
analyzed by performing syngeneic tumor implant studies. While there was significant growth 
inhibition of B16 melanoma tumors implanted in Antxr1 KO mice, the growth delay did not correlate 
with significant differences in tumor vessel density or pericyte coverage. There were no detectable 
differences between WT and KO tumors when evaluating tumor endothelial cell apoptosis, tumor 
endothelial cell proliferation, tumor hypoxia, or tumor macrophage content. Thus, the mechanism by 
which Antxr1 contributes to tumor growth in this particular study was not delineated but clearly 
involved a stromal component of the tumor microenvironment. A recent follow-up study using these 
Antxr1 KO mice bred to an immunodeficient background revealed slower growth of multiple human 
tumor xenografts that was due in part to reduced tumor vasculature [20,21]. Since the ANTXRs are 
highly expressed on tumor vasculature, it is logical to hypothesize that targeting the receptors might 
serve as a potential new strategy for developing anti-angiogenic therapies to treat cancer. Numerous 
studies addressing this hypothesis have been published and will not be elaborated upon in this review, 
as this topic is amply covered in the literature [9,21].  
As Antxr1 KO mice develop normally and thrive but fail to support strong tumor growth, it has 
been hypothesized that a key function of ANXTR1 may be to serve in stress-mediated responses [21]. 
This concept fits with the observation that TEM8 is highly expressed in endothelial cells in the 
stressful environment of a growing tumor. In fact, Chaudhary and St. Croix found that TEM8 is 
induced in cultured endothelial cells upon growth factor deprivation [20] or amino acid starvation [21], 
two conditions that tumor endothelial cells may be exposed to. 
The predominant phenotype documented in the Antxr1 KO mice was excessive deposition of 
extracellular matrix proteins, such as type I collagen and type VI collagen [19]. This ECM homeostasis 
defect was seen in numerous organs including the ovaries, uterus and skin and was documented in 
Antxr1 KO mice that were 6 to 8 months old. The Antxr1 KO mice displayed progressive misalignment 
of the incisors, similar to what had been reported for the Antxr1 mutant mice [18,19]. While female 
Antxr1 mutant mice displayed a fertility defect [18], male and female Antxr1 KO mice were reported  
to be fertile when mated at 5 weeks of age and when analyzing litters born within the first 2 months  
of breeding [19]. Thus, it remains to be determined if older female Antxr1 KO mice exhibit  
fertility defects.  
While human ANTXR1 was originally reported to be a tumor endothelial marker, the Antxr1 KO 
mouse phenotype suggested more widespread expression of Antxr1, as ECM homeostasis defects are 
seen in tissues and cell types beyond tumor endothelium. Other studies support this supposition, 
demonstrating a more widespread pattern of Antxr1 expression at both the transcript and protein level 
in a variety of tissues including the skin, lung, intestine, brain, heart, kidney, spleen, liver, adrenal 




gland, thymus, muscle, pancreas, ovary and testis [8,18,22]. The Antxr1 KO phenotype also supports 
the inclusion of uterus, incisors, bladder, stomach and tongue among the organs expressing  
Antxr1 [19]. Thus, ANTXR1 is highly expressed in tumor endothelium, functions in tumor growth, 
and appears to regulate ECM homeostasis in several organs of the mouse. 
5. Antxr2 Knockout Mice Exhibit Defective Parturition and Aberrant ECM Remodeling in the 
Reproductive Tract 
The Kitajewski group generated Antxr2 KO mice by targeting exon 1 for deletion [23]. Antxr2 is 
not essential for normal development as heterozygous intercrosses yielded Antxr2 KO mice in the 
expected Mendelian ratios. However, female Antxr2 KO mice exhibited reproductive defects that 
varied with age: young mice exhibited a parturition defect while older mice were infertile.  
When mated at 6 weeks of age, Antxr2 KO mice became impregnated but could not give birth on 
the expected due date. Analysis of the pregnant Antxr2 KO reproductive tract near term revealed loss 
of the circular and longitudinal myometrial cell layers, the cells that produce uterine contractions. 
There was increased collagen deposition in what appeared to have been the myometrial layers. The 
Antxr2 KO cervical stroma was collagen dense, indicating defective cervical remodeling. Thus, the 
block in the ability to give birth was due to defects in two processes required for successful parturition: 
coordinated uterine contractions and cervical ripening [23].  
Older sexually mature Antxr2 KO female mice, aged 2 to 6 months, would either miscarry their 
litters or exhibit parturition defects, as described above. Antxr2 KO mice aged 7 months and beyond 
were not able to get pregnant. These age related changes in fertility suggested defects in the Antxr2 KO 
reproductive tracts in the non-pregnant state upon aging. Reproductive tracts from 1-month-old 
prepubescent WT and Antxr2 KO mice appeared similar. Reproductive tracts isolated from aged, 
sexually mature nulliparous Antxr2 KO mice had a shortened, thickened shape in comparison to the 
thin, elongated reproductive tracts from WT animals. Histological analysis of the uterus and cervix 
showed aberrant deposition of ECM proteins including type I collagen, type VI collagen and 
fibronectin. The aberrant ECM deposition was progressive with age and caused severe disorganization 
of the cellular composition of these tissues such that normal uterine architecture was destroyed [23].  
A subsequent report of Antxr2 mutant mice, generated by targeting exon 12 for deletion, also 
describes a reproductive phenotype due to mutation of the Antxr2 gene [24]. This targeting strategy 
produces an Antxr2 protein consisting of the extracellular domain [18] and this secreted Antxr2 variant 
could still have functional relevance. The parturition defect in the Antxr2 mutant mice was similar to 
the defect described above, highlighting that either complete loss of Antxr2 protein [23] or generation 
of a protein lacking the transmembrane domain [24] results in parturition defects in mice.  
Thus, the Antxr2 deficient phenotypes confirmed findings from analysis of Antxr1 mutant  
mice [19]: the ANTXRs function in ECM homeostasis. However, the spectrum of tissues displaying 
ECM homeostasis defects differed for Antxr1 mutant mice and Antxr2 mutant mice. Unlike what had 
been observed for Antxr1 KO mice, the ovaries from 6-month-old Antxr2 KO mice did not reveal overt 
changes in ECM content that might interfere with follicular maturation or oocyte production  
and release [19,23]. Thus, impaired fertility in older Antxr2 KO mice likely resulted from defects in 
uterine receptivity.  




6. Antxr Knockout Studies Suggest Functionally Redundant Roles for ANTXR1 and ANTXR2 in 
ECM Remodeling  
There is likely to be overlap in Antxr1 and Antxr2 expression and function in light of the fact that 
mutant mice in either of these genes display an ECM homeostasis defect. Like Antxr1, expression of 
Antxr2 mRNA and protein is found in many organs including kidney, liver, lung, placenta, spleen, 
skeletal muscle, heart, skin, intestine, mammary gland and uterus [2,12,23]. Based on studies in mice, 
both receptors are expressed in lung, intestine, skin and uterus [12,19,22,23]. No co-expression studies 
have been published to date and this careful comparison may require the use of specific antibodies that 
recognize one receptor or the other, and which exhibit no cross reactivity. If one focuses on tissues that 
are known to require both Antxrs for normal function, loss of either Antxr1 or Antxr2 led to aberrant 
ECM accumulation in the uterus [19,23,24]. The increased ECM deposition in the uterus of Antxr1 KO 
mice or Antx2 KO mice suggests that both Antxrs function as regulators of ECM remodeling in the 
uterus. In Antxr1 KO mice, there was also aberrant ECM deposition in the skin and intestine [19]. 
However, it is currently unknown if a similar phenotype is observed in Antxr2 KO mice. Future studies 
with Antxr1; Antxr2 double KO mice will help to elucidate if ANTXRs are fully or partially 
functionally redundant. 
7. The ANTXRs Regulate MT1-MMP Activity 
The ECM remodeling defects in the Antxr2 KO suggested a defect in MMP activity in the mutant 
mice [23]. Gelatin zymography, used to evaluate the activity of MMP2 and MMP9, revealed reduced 
levels of active MMP2 in conditioned medium from Antxr2 KO mouse embryonic fibroblasts (MEFs) 
when compared to WT MEFs. This observation was extended to the reproductive tract by assessing 
MMP2 processing in uterine lysates from Antxr2 WT and KO mice. Increased levels of pro MMP2 and 
reduced levels of active MMP2 were found in the Antxr2 KO uterine lysates when compared to WT 
lysates. The intermediate form of MMP2 was not detected in the Antxr2 KO lysates but was detected 
in WT lysates. These experiments suggested that MMP2 activation, a process mediated by MT1-MMP, 
was defective in the Antxr2 KO female mice [23]. 
MMP2 is a member of the matrix metalloproteinase (MMP) family, a group of zinc containing 
endoproteases that degrade ECM components that are grouped by protein structure and substrate 
specificity. MMP2 is known to degrade a variety of substrates including gelatin, collagens, fibronectin, 
laminin (reviewed in [25]). Pro-MMP2 is secreted as a zymogen and is activated at the cell surface by 
MT1-MMP and TIMP-2 [25–28]. MT1-MMP has a transmembrane and cytoplasmic domain, and is 
found on the cell surface in its active form. MT1-MMP is capable of activating other MMPs via a 
proteolytic mechanism, and it also cleaves a variety of ECM substrates ( [27] and reviewed 
in [25,29,30]). TIMP-2 is part of the family of secreted, homologous tissue inhibitors of 
metalloproteinases (TIMPs) [25,29,30]. As their name suggests, TIMPs were originally thought to 
inhibit MMP activity, but further studies showed that they also facilitate MMP activation in a context 
specific manner. TIMP-2 is commonly described as the endogenous inhibitor of MT1-MMP because 
high concentrations of TIMP-2 inhibit all MT1-MMP proteolytic activity. However, low 




concentrations of TIMP-2 facilitate formation of a TIMP-2/MT1-MMP/pro-MMP2 ternary complex as 
described below [25,31].  
The classic model of pro-MMP2 activation is well studied (reviewed in [25]) and schematized in 
Figure 1A. MT1-MMP localized in the plasma membrane, binds to the N terminus of TIMP-2 to form 
a receptor for pro-MMP2. An adjacent TIMP-2-free MT1-MMP cleaves the pro MMP2 in the  
TIMP-2/MT1-MMP/pro-MMP2 complex to release an intermediate form of MMP2. An autocatalytic 
event then produces the fully activated form of MMP2 [26,32].  
Our published report [23] suggested that the ANTXRs might be involved in this MMP2 activation 
complex, and one may propose that ANTXRs carry out this function via an association with  
MT-MMPs, as schematized in Figure 1B. Investigation of this hypothesis led to the discovery that both 
ANTXR1 and ANTXR2 positively regulate MT1-MMP activity in cultured cells [23]. Gelatin 
zymography on cultured cell media revealed that co-expression of MT1-MMP and either ANTXR1 or 
ANTXR2 consistently led to increased levels of MMP2 activation, as compared to cells expressing 
MT1-MMP alone. Moreover, the Mt1-mmp and Antxr2 proteins co-localize on the cell surface of 
MEFs and co-immunoprecipitation experiments confirmed that MT1-MMP and ANTXR proteins are 
found in a complex [23]. 
To initiate a discussion on how these proteins work, we propose that interactions between ANTXR 
and ECM components may promote multimerization and activation of a pericellular  
ANTXR/MT1-MMP complex (see Figure 1B). This hypothesis posits that the fibrosis present in 
various organs of Antxr1 KO mice and both the pregnant and nonpregnant uterus and cervix of Antxr2 
KO mice are the result of reduced Mt1-mmp and Mmp2 proteolytic activity. This working model will 
depend on validation by further biochemical assessments, now facilitated by access to Antxr-deficient 
cell lines [19,23]. ECM homeostasis is a complex process that likely derives from a variety of 
enzymatic influences. Among those influences, we must include ANTXR1 and ANTXR2. Future 
investigation of this exciting topic will help our understanding of anthrax intoxication, fibrosis, and 
normal tissue physiology. 
8. Are the Physiological Functions of Anthrax Toxin Receptors Important for Anthrax Intoxication? 
Anthrax intoxication has been well studied, though questions surrounding the process still remain 
(reviewed in [3,4,17,33]) During anthrax intoxication, protective antigen (PA) binds to ANTXRs on 
the surface of target cells and mediates delivery of lethal factor (LF) and edema factor (EF) into the 
cytosol. Upon ANTXR binding, PA is cleaved by furin, a protease that has low expression in many 
cell types, and that is anchored to the golgi apparatus and plasma membranes [34,35]. While previous 
studies have established that furin cleaves PA, there is currently no data to indicate whether PA 
recruits furin on its own or if it takes advantage of the ANTXR’s ability to do so. Furin mediated 
cleavage of PA results in two PA fragments, PA63 and PA20. The PA63 fragment stays bound to the 
ANTXR and self associates to form a heptameric precursor pore. This “prepore” binds up to three 
molecules of lethal factor (LF) and edema factor (EF) and translocates into the cytoplasm of target 
cells. There, EF promotes the formation of cAMP, and LF proteolytically inactivates MAPKKs 
(reviewed in [3,4,17,33]). In the model of anthrax intoxication, ANTXRs are mostly regarded as the 
means of translocating the toxin into target cell. Mice lacking full function of Antxr1, Antxr2, or 




double mutants have been used to evaluate receptor function in mediating lethality due to toxin 
exposure in vivo [36]. These studies have established ANTXR2 as the primary anthrax toxin receptor 
in vivo, with ANTXR1 relegated to a minor role [36]. 
As discussed in this review, ANTXRs function as regulators of MT1-MMP activity, cell-matrix 
interactions and ECM remodeling. Could ANTXR regulation of MT1-MMP activity be relevant during 
anthrax pathogenesis? Using in vitro cell-free system and cultured human cancer cells, PA was 
identified as a substrate of MT1-MMP [37]. MT1-MMP is a protease that is activated by furin [38], 
and like furin, MT1-MMP exhibits localization on the plasma membrane [27,38]. Previous studies 
have revealed that MT1-MMP can perform self-cleavage of its pro domain at the furin cleavage  
motif [39]. This suggested that MT1-MMP and furin have similar substrates. In the study by Rozanov 
and colleagues [37], MT1-MMP cleaved both PA83 and PA63 at the cell surface, promoting resistance 
to anthrax toxin. Thus, while furin cleavage of PA promotes cellular intoxication, MT1-MMP cleavage of 
PA presumably inhibits this process. It remains to be determined if MT1-MMP cleaves PA in macrophages 
or other cell types that are implicated during anthrax intoxication [40]. If MT1-MMP cleavage of PA is 
shown to occur in relevant cell types, then it would suggest that in addition to expression of ANTXRs [41], 
susceptibility to anthrax toxin is also influenced by expression of MT1-MMP.  
9. Conclusions  
Studies of the Antxr1 and Antxr2 KO mouse phenotypes revealed a critical role for the ANTXR 
proteins in regulating ECM homeostasis. ANTXRs may facilitate ECM remodeling through their 
interaction with, and promotion of, MT1-MMP activity. It remains to be determined if the ANTXRs 
regulate the activity of other MMPs, or other proteases that are known to have a role in ECM 
remodeling. Does ANTXR primarily target the MT-MMP activation cascade or does the ECM 
homeostasis defect found in Antxr mutant mice include miss-regulation of other proteins involved in 
ECM biosynthesis and breakdown? These open questions will undoubtedly benefit from the mouse 
models generated thus far, which have been instrumental in understanding and exploring ANTXRs 
function in mammals.  
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